VolitionRx partners with Sysmex to optimize Nu.Q® NETs assay

VolitionRx Limited (VNRX) has entered into a strategic collaboration agreement with global in vitro diagnostics leader Sysmex ...

Sysmex launches HISCL™ platform, enabling faster, scalable Alzheimer's blood testing

Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL™ p-Tau217 RUO* and the HISCL™ ...

VolitionRx Announces Collaboration with Sysmex

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration with Sysmex (TYO: 6869), a leader in global in vitro diagnostics, to optimize ...
Business Wire

Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration

TOKYO & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement ...
Technical

Sysmex Inostics moves into bigger space near JHU medical campus

The company, which is rooted in pioneering cancer research at Johns Hopkins, is growing in Baltimore as it looks to stay near the university. Executives from Japan marked the opening recently on a U.S ...
Business Wire

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing

MINATO-KU, TOKYO, Japan & KOBE, Japan--(BUSINESS WIRE)--Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a ...
Pharmabiz

Sysmex introduces CyFlow antibodies for use in flow cytometry applications

Sysmex America has announced that as part of its initiative to offer cutting edge clinical laboratory products, the introduction of CyFlow Antibodies; a comprehensive portfolio of Analyte Specific ...
Nature

Sysmex Corporation

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
technologynetworks

Sysmex and LabCorp Announce a Strategic Collaboration

Sysmex Corporation and Laboratory Corporation of America® Holdings (LabCorp®) have announced a strategic collaboration focused on the development of blood-based molecular diagnostic tests to advance ...

Sysmex Europe SE: Sysmex launches HISCL platform, enabling faster, scalable Alzheimer's blood testing

Independent European studies presented at CTAD 2025 and ADPD2026 confirmed that the HISCL p-Tau217 RUO* and the HISCL Aß42/40 ratio are highly ...

VolitionRx Limited: VolitionRx Announces Collaboration with Sysmex

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces a collaboration ...
Morningstar

Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing

Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa; “Fujirebio”), a consolidated subsidiary of H.U. Group Holdings, Inc. (HQ: Minato ...